Parkinson's Disease as a Risk Factor for Prostate Adenocarcinoma: a Molecular Point of View

Conclusion: Bioinformatics was used to identify potential targets and novel molecular mechanisms that may serve as clinical markers for the diagnosis and treatment of PD and PRAD.
Source: Gerontology - Category: Geriatrics Source Type: research